Download PDF
Semin Thromb Hemost
DOI: 10.1055/s-0044-1801825
Review Article

Venous Thromboembolism Occurrence and Association with Gastrointestinal Disorders in Children with Cystic Fibrosis: An Analysis from the TriNetX Research Network Global Multicenter Real-World Dataset

Carolena Trocchia
1   Department of Pediatric Gastroenterology, Lucille Packard Children's Hospital of Stanford, Palo Alto, California
,
Dina Ashour
2   Epidemiology/Biostatistics Unit, Johns Hopkins All Children's Hospital and Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida
,
Maua Mosha
3   Department of Pediatric Gastroenterology, University of South Florida Morsani College of Medicine, Tampa, Florida
,
Bailey Hamner
3   Department of Pediatric Gastroenterology, University of South Florida Morsani College of Medicine, Tampa, Florida
4   Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
,
Marisol Betensky
5   Department of Hematology and Oncology, Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
,
Neil Goldenberg
6   Department of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
7   Department Research, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida
,
Racha Khalaf
3   Department of Pediatric Gastroenterology, University of South Florida Morsani College of Medicine, Tampa, Florida
8   Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, Florida
› Author Affiliations Funding This work was supported by an institutional research award from the Johns Hopkins All Children's Foundation. This resource provided funding for statistical support and analysis along with use of the TriNetX database with safe storage of data. This resource did not influence the choice of the type of manuscript or journal chosen for publication. This work was also supported by a Harry Shwachman Cystic Fibrosis Clinical Investigator Award (#005206Q123) and a Cystic Fibrosis Foundation, Research Additional Mentoring Program Award (005583Q123) to Racha Khalaf.
› Further Information
    Permissions and Reprints

Abstract

The purpose of this study is to (1) estimate and compare the prevalence of venous thromboembolism (VTE) in children (age 0 to ≤21) with versus without cystic fibrosis (CF); (2) investigate putative associations between specific gastrointestinal (GI) manifestations and the development of VTE among children with CF. This was a multicenter case–control analysis among patients aged 0 to ≤ 21 years between 2010 and 2020, using the TriNetX Research Network. Data queries included ICD-9/10 (International Classification of Diseases-9th/10th Revision) diagnosis codes. Bivariate associations with VTE among CF patients were compared using Chi-square testing for categorical variables and Student's t-test for continuous variables. We used multivariable logistic regression to test for independent associations of GI manifestations with VTE among children with CF, with adjustment for other salient covariates. There was a total of 7,689 children with and 22,327,660 without CF. The frequency of occurrence of VTE was increased nearly 20-fold among those with, as compared with without CF (130 vs. 7 per 10,000 patients). Acute pancreatitis (adjusted odd ratio [aOR] = 3.80, [95% confidence interval, CI: 2.00–7.22]), biliary disease (aOR = 2.17 [95% CI: 1.17–4.03]), gastrostomy status (aOR = 2.01 [95% CI: 1.27–3.18]), and malabsorption/malnutrition (aOR = 2.41 [95% CI: 1.52–3.82]) were each associated with a higher likelihood of VTE among children with CF. In conclusion, we found a significantly increased frequency of VTE occurrence and association of specific GI diseases as independent risk factors for VTE among children with CF compared with those without.

Keywords

cystic fibrosis - gastrointestinal manifestations - venous thromboembolism - medications

Authors' Contributions

Carolena Trocchia: conceptualization, data curation, funding acquisition, investigation, resources, original draft, review, and editing.


Dina Ashour: project administration, software, formal analysis, resources, review, and editing.


Maua Mosha: conceptualization, data acquisition, formal analysis, project administration, software, resources, review, and editing.


Marisol Betensky: investigation, resources, review, and editing.


Neil Goldenberg: conceptualization, data curation, investigation, resources, review and editing, and supervision.


Racha Khalaf: conceptualization, data curation, investigation, funding acquisition, resources, review and editing, and supervision.




Publication History

Article published online:
13 January 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Dickinson KM, Collaco JM. Cystic fibrosis. Pediatr Rev 2021; 42 (02) 55-67
    CrossrefPubMedSearch in Google Scholar
  • 2 Sathe MN, Freeman AJ. Gastrointestinal, pancreatic, and hepatobiliary manifestations of cystic fibrosis. Pediatr Clin North Am 2016; 63 (04) 679-698
    CrossrefPubMedSearch in Google Scholar
  • 3 Kamal N, Surana P, Koh C. Liver disease in patients with cystic fibrosis. Curr Opin Gastroenterol 2018; 34 (03) 146-151
    CrossrefPubMedSearch in Google Scholar
  • 4 Demeyer S, De Boeck K, Witters P, Cosaert K. Beyond pancreatic insufficiency and liver disease in cystic fibrosis. Eur J Pediatr 2016; 175 (07) 881-894
    CrossrefPubMedSearch in Google Scholar
  • 5 Birimberg-Schwartz L, Wilschanski M. Cystic fibrosis related gastrointestinal manifestations - moving forward. J Cyst Fibros 2021; 20 (04) 562-563
    CrossrefPubMedSearch in Google Scholar
  • 6 Zuloaga N, Vivallos N, Faúndez R. et al. Gastrointestinal manifestations of cystic fibrosis in children [in Spanish]. Andes Pediatr 2021; 92 (04) 526-533
    PubMedSearch in Google Scholar
  • 7 Thomas L, Kumar M, Lionel BAP, Varkki S, Rebekah G. Pancreatic, hepatobiliary, and gastrointestinal manifestations of children with cystic fibrosis: a 10-year experience from a tertiary care center in southern India. Indian J Gastroenterol 2022; 41 (03) 266-272
    CrossrefPubMedSearch in Google Scholar
  • 8 Tam RY, van Dorst JM, McKay I, Coffey M, Ooi CY. Intestinal inflammation and alterations in the gut microbiota in cystic fibrosis: a review of the current evidence, pathophysiology and future directions. J Clin Med 2022; 11 (03) 649
    CrossrefPubMedSearch in Google Scholar
  • 9 Thavamani A, Salem I, Sferra TJ, Sankararaman S. Impact of altered gut microbiota and its metabolites in cystic fibrosis. Metabolites 2021; 11 (02) 123
    CrossrefPubMedSearch in Google Scholar
  • 10 O'Brien SH, Stanek JR, Witmer CM, Raffini L. The continued rise of venous thromboembolism across US children's hospitals. Pediatrics 2022; 149 (03) e2021054649
    CrossrefPubMedSearch in Google Scholar
  • 11 Morrison JM, Betensky M, Kiskaddon AL, Goldenberg NA. Venous thromboembolism among noncritically ill hospitalized children: key considerations for the pediatric hospital medicine specialist. Semin Thromb Hemost 2022; 48 (04) 434-445
    Thieme ConnectPubMedSearch in Google Scholar
  • 12 Abrams CM, Jaffray J, Stillings A. et al; CHAT Consortium Investigators, VTE Risk Factors and Thromboprophylaxis Working Group of the Pediatric and Neonatal Thrombosis and Hemostasis Subcommittee of the ISTH SSC. Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium. Res Pract Thromb Haemost 2022; 6 (07) e12793
    CrossrefPubMedSearch in Google Scholar
  • 13 Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr 2018; 6: 142
    CrossrefPubMedSearch in Google Scholar
  • 14 Knight-Perry J, Branchford BR, Thornhill D, Martiniano SL, Sagel SD, Wang M. Venous thromboembolism in children with cystic fibrosis: retrospective incidence and intrapopulation risk factors. Thromb Res 2017; 158: 161-166
    CrossrefPubMedSearch in Google Scholar
  • 15 Williams V, Griffiths AB, Yap ZL. et al. Increased thrombophilic tendency in pediatric cystic fibrosis patients. Clin Appl Thromb Hemost 2010; 16 (01) 71-76
    CrossrefPubMedSearch in Google Scholar
  • 16 Takemoto CM. Venous thromboembolism in cystic fibrosis. Pediatr Pulmonol 2012; 47 (02) 105-112
    CrossrefPubMedSearch in Google Scholar
  • 17 Ratté MT, Jones AE, Witt DM, Young DC. Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosis. Pediatr Pulmonol 2020; 55 (01) 149-155
    CrossrefPubMedSearch in Google Scholar
  • 18 Raffini LJ, Raybagkar D, Blumenstein MS, Rubenstein RC, Manno CS. Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. J Pediatr 2006; 148 (05) 659-664
    CrossrefPubMedSearch in Google Scholar
  • 19 Betensky M, Amankwah E, Hankins J, Goldernberg N. High rate of recurrent venous thromboembolism is children with sickle cell disease and history of VTE: analysis of the Trinetx Research Network Database. Blood 2021; 138 (01) 778
    CrossrefPubMedSearch in Google Scholar
  • 20 Balfour-Lynn IM, Malbon K, Burman JF, Davidson SJ. Thrombophilia in children with cystic fibrosis. Pediatr Pulmonol 2005; 39 (04) 306-310
    CrossrefPubMedSearch in Google Scholar
  • 21 Khan MA, Ali ZS, Sweezey N, Grasemann H, Palaniyar N. Progression of cystic fibrosis lung disease from childhood to adulthood: neutrophils, neutrophil extracellular trap (NET) formation, and NET degradation. Genes (Basel) 2019; 10 (03) 183
    CrossrefPubMedSearch in Google Scholar
  • 22 Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 2023; 20 (04) 248-262
    CrossrefPubMedSearch in Google Scholar
  • 23 Folsom AR, Basu S, Hong CP. et al; Atherosclerosis Risk in Communities (ARIC) Study. Reasons for differences in the incidence of venous thromboembolism in Black versus White Americans. Am J Med 2019; 132 (08) 970-976
    CrossrefPubMedSearch in Google Scholar
  • 24 Chung WS, Lin CL. Association between venous thromboembolism and acute pancreatitis: an analysis from the nationwide inpatient sample. Clin Respir J 2020; 14 (04) 320-327
    CrossrefPubMedSearch in Google Scholar
  • 25 Hassam A, Manickam S, Pamarthy R. et al. Acute venous thromboembolism in acute pancreatitis based on the severity: a retrospective cohort study. J Pancreatol 2022; 5 (01) 10-17
    CrossrefPubMedSearch in Google Scholar
  • 26 Ahmad DS, Mansoor E, Alikhan MM. et al. Risk of venous thromboembolism in acute necrotizing pancreatitis: a large database study. Pancreas 2021; 50 (01) 71-76
    CrossrefPubMedSearch in Google Scholar
  • 27 Kylänpää L, Rakonczay Jr Z, O'Reilly DA. The clinical course of acute pancreatitis and the inflammatory mediators that drive it. Int J Inflamm 2012; 2012: 360685
    PubMedSearch in Google Scholar
  • 28 Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol 2016; 99: 272-285
    CrossrefPubMedSearch in Google Scholar
  • 29 Singh H, Jani C, Marshall DC. et al. Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities. Sci Rep 2023; 13 (01) 15030
    CrossrefPubMedSearch in Google Scholar
  • 30 Baldissera M, Lewindon PJ, Ramm LE, Hartel GF, Mattiello R, Ramm GA. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: a 27-year real-life cohort study. J Cyst Fibros 2022; 21 (02) 230-235
    CrossrefPubMedSearch in Google Scholar
  • 31 Chen CH, Lin CL, Kao CH. The risk of venous thromboembolism in patients with gallstones. Int J Environ Res Public Health 2020; 17 (08) 2930
    CrossrefPubMedSearch in Google Scholar
  • 32 Sun H, Warren J, Yip J. et al. Factors influencing gallstone formation: a review of the literature. Biomolecules 2022; 12 (04) 550
    CrossrefPubMedSearch in Google Scholar
  • 33 Culhane S, George C, Pearo B, Spoede E. Malnutrition in cystic fibrosis: a review. Nutr Clin Pract 2013; 28 (06) 676-683
    CrossrefPubMedSearch in Google Scholar
  • 34 Zientek E, Rane S, Godfrey C, Sisson A, Dickinson KM. Factors guiding gastrostomy tube decision-making for caregivers of children with cystic fibrosis: a scoping review protocol. BMJ Open 2023; 13 (12) e076539
    CrossrefPubMedSearch in Google Scholar
  • 35 Shimmin D, Lowdon J, Remmington T. Enteral tube feeding for cystic fibrosis. Cochrane Database Syst Rev 2019; 7 (07) CD001198
    PubMedSearch in Google Scholar
  • 36 Kelly T, Buxbaum J. Gastrointestinal manifestations of cystic fibrosis. Dig Dis Sci 2015; 60 (07) 1903-1913
    CrossrefPubMedSearch in Google Scholar
  • 37 Pantic N, Pantic I, Jevtic D. et al. Celiac disease and thrombotic events: systematic review of published cases. Nutrients 2022; 14 (10) 2162
    CrossrefPubMedSearch in Google Scholar